Six Action Steps to Address Global Disparities in Parkinson Disease
JAMA Neurology2022Vol. 79(9), pp. 929–929
Citations Over TimeTop 1% of 2022 papers
Nicoline Schiess, Rodrigo Cataldi, Michael S. Okun, Natasha Fothergill‐Misbah, E. Ray Dorsey, Bastiaan R. Bloem, Maria Barretto, Roongroj Bhidayasiri, R. J. Brown, Lorraine Chishimba, Neerja Chowdhary, Max Coslov, Esther Cubo, Alessandro Di Rocco, Rachel Dolhun, Christopher Dowrick, Victor S.C. Fung, Oscar S. Gershanik, Larry Gifford, Joyce Gordon, Hanan Khalil, Andrea A. Kühn, Sara Lew, Shen‐Yang Lim, Maria Marano, Jacquie Micallef, Jolynne Mokaya, Emile Moukheiber, Lynda Nwabuobi, Njideka Okubadejo, Pramod Kumar Pal, Hiral Shah, Ali Shalash, Todd Sherer, Bernadette Siddiqui, Ted Thompson, Andreas Ullrich, Richard Walker, Tarun Dua
Abstract
The dramatic increase of PD cases in many world regions and the potential costs of PD-associated treatment will need to be addressed to prevent possible health service strain. Across the board, governments, multilateral agencies, donors, public health organizations, and health care professionals constitute potential stakeholders who are urged to make this a priority.
Related Papers
- → The global, regional, and national disease burden of breast cancer attributable to low physical activity from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019(2022)51 cited
- Updated Estimates of Burden Due to Mental and Substance Use Disorders from the Global Burden of Disease Study 2013(2015)
- → The Burden of Breast Cancer in Sub-Saharan Africa: A Systematic Analysis from the Global Burden of Disease 2019 study.(2024)
- → Assessment of the global burden of esophageal cancer from 1990 to 2021 and the forecasted global burden in 2050: Results from the Global Burden of Disease Study 2021(2024)
- National Burden of Eye Diseases in Iran 1990-2010; Findings from the Global Burden of Disease Study 2010(2014)